October is National Depression and Mental Health Screening Month

Mental illnesses are still often overlooked despite being widespread: 5% of global population suffer from Depression alone.

It is important to recognize and address the problem of mental illnesses at early stages to increase the effectiveness of treatment. Many treatment methods are available for mild to severe depression including therapy and medications. Furthermore, new therapies are being developed continuously.

GCT specializes on CNS and Neurology drug development. For more information about GCT experience in clinical trials, please contact us at bd@gctrials.com.

Subscribe to our mailing list

Marketing Permissions

Please select all the ways you would like to hear from Global Clinical Trials (GCT):

You can unsubscribe at any time by clicking the link in the footer of our emails. Please see our Privacy Policy. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.


GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login



© 2001—2021 Global Clinical Trials, LLC

All rights reserved.